BioSpace News Archive

The Muscular Dystrophy Association celebrates the US Food and Drug Administration approval of sodium phenylbutyrate/taurursodiol for the treatment of amyotrophic lateral sclerosis, on September 29.

Latest Study on “Psoriasis Treatment Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030”.

Ashvattha Therapeutics announced preclinical data presented by collaborators from Stanford University demonstrating that its hydroxyl dendrimer -based PET tracer, [18F]OP-801, can detect activated macrophages and microglia with high sensitivity and specificity in an experimental autoimmune encephalomyelitis murine model of multiple sclerosis, in addition to being reproducibly synthesized and suitable for human use.

Iowa Cancer Specialists announced that The DigniCap® Scalp Cooling System is now available at 1750 E 53rd Street in Davenport to minimize hair loss from chemotherapy.

BioMarin Pharmaceutical Inc. announced that the Company resubmitted a Biologics License Application to the U.S. Food and Drug Administration for its investigational AAV gene therapy, valoctocogene roxaparvovec, for adults with severe hemophilia A.

Scribe Therapeutics Inc. announced it will participate in two upcoming investor conferences: Scribe co-founder and CEO Benjamin Oakes will participate in a panel titled “Gene Editing: Next-Generation Technologies Worth Watching,” at 9:30 a.m. ET on Oct. 3, 2022, at the Chardan Genetic Medicines Conference in New York, NY.

Artivion, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced the appointment of Elizabeth A. Hoff to its Board of Directors effective October 1, 2022.

Last spring, a rapid polymerase chain reaction test for COVID-19 — developed by Northwestern University spinoff company Minute Molecular Diagnostics — received emergency use authorization status from the U.S. Food and Drug Administration.

Amylyx Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has approved RELYVRIO™ for the treatment of adults with amyotrophic lateral sclerosis.

Latest Study on “Meningococcal Vaccines Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030”.